Advertise your Pathology Conferences and Webinars with us!
To advertise on this popular page, email your text, graphics and contact information to Ads@PathologyOutlines.com. If no response within 1 business day, please resend and CC Rosie@PathologyOutlines.com. Ads are posted until the conference / webinar date. Email us once you have the date and we will create a Save the Date ad to use until you get your official ad; there is no additional charge for changes or for rescheduling due to the COVID-19 pandemic. After posting, we will send you a confirmation email and invoice; please use the link at the bottom of the invoice to pay. Prepayment may be required.
We have these options for posting:
(a) $700 for a highlighted listing (most of the ads below are highlighted listings) with graphics, text and links
(b) $800 for option (a) plus a CME page posting for offerings related to this conference
(c) $400 for a one line listing (date, location, title and link)
(d) $1,100 to add a standard E-blast or social media posting (more information)
(e) $750 to add a banner for one month on the Conferences page (top: 728x90, side: 300x250)
(f) $4,200 for a package of 6 highlighted listings plus one E-blast or social media posting plus an Organization listing
(g) Contact us for additional promotional packages at (248) 646-0325 or Ads@PathologyOutlines.com.
Links to all recent posts are included in an E-blast sent biweekly to 7,251 subscribers for no additional charge. Frequently asked questions Testimonials
Map of US with regions
USCAP Presents:
Modern Approaches to Classification of Hematolymphoid Neoplasms
Accurate diagnosis in hematopathology relies heavily on the complex integration of data from clinical presentation, conventional microscopy, immunohistochemistry, flow cytometry, and molecular and cytogenetic analyses. Diagnosis is often complicated by the fact that clinically relevant disease subsets can share overlapping diagnostic features, and both baseline appreciation for disease spectrum and appropriate application/interpretation of ancillary testing is lacking. This gap can lead to real and immediate clinical consequences for therapeutic selection and overall patient management.
While in-house testing for the vast array of available diagnostic, prognostic and predictive markers is not possible in every setting or practice, awareness of their applicability and impact on patient care is the responsibility of both the pathologist and treating clinician. This is particularly true in an era when patients are increasingly knowledgeable about genomic and proteomic analyses and the studies are easily accessible. Approaching this target by strengthening baseline knowledge and skill in application empowers the pathologist as a consultant to the clinical care team.
This superb faculty will synthesize and deliver this strategic philosophy in the context of intimate mentoring and personalized attention to detail.
Course Location: Palm Springs, CA
Course Directors: Olga K. Weinberg, MD and Yuri Fedoriw, MD